Sprott Announces Date for 2025 Third Quarter Results Webcast GlobeNewswire October 30, 2025 TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE:SII) (TSX:SII) (“Sprott”) announced today that it plans to release its 2025 third quarter results at 7:00 a.m. on November 5, 2025. Sprott will host an earnings webcast that morning at 10:00 a.m. […]

SYDNEY, Oct. 30, 2025 (GLOBE NEWSWIRE) — Axi, a financial leader in online CFD and FX trading, participated in iFX Expo Asia 2025, held from October 26 to 28, in Asia. The event brought together leading fintech, trading, and financial services professionals from across the globe. Event attendees had the opportunity to explore the Axi

Syndax Announces Participation in November Investor Conferences GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming

Aduro Clean Technologies Provides Update on NGP Pilot Plant Commissioning GlobeNewswire October 30, 2025 LONDON, Ontario, Oct. 30, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen,

Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company's Board of Directors GlobeNewswire October 30, 2025 FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that Carsten Brunn, Ph.D., was named as Chairman of

Gain Therapeutics to Present at Neuroscience 2025 GlobeNewswire October 30, 2025 BETHESDA, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced a poster presentation at the Society for

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance GlobeNewswire October 30, 2025 Previously reported data showed that in a diet-induced obesity mouse model, IBIO-610 drives fat-selective, GLP-1-synergistic weight loss and prevents weight regain following GLP-1 treatment discontinuation New non-human primate data

CropLife Canada Urges Bold Action to Unlock Agricultural Productivity Growth and Strengthen the Economy GlobeNewswire October 30, 2025 OTTAWA, Ontario, Oct. 30, 2025 (GLOBE NEWSWIRE) — CropLife Canada is calling on the federal government to prioritize agriculture by making bold and decisive policy changes that can help unlock over $100B in GDP growth over the

HPQ Receives First Industrial Shipments of HPQ ENDURA+ Batteries With the first ENDURA+ batteries now in hand, HPQ prepares to distribute samples for field testing and advance toward full-scale commercialization GlobeNewswire October 30, 2025 MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a

Abercrombie & Fitch and Luxury Retailer Kemo Sabe Debut Western-Inspired Collaboration The apparel and accessories collection represents the first collaboration of its kind for Kemo Sabe GlobeNewswire October 30, 2025 NEW ALBANY, Ohio, Oct. 30, 2025 (GLOBE NEWSWIRE) — Abercrombie & Fitch (Abercrombie), a division of Abercrombie & Fitch Co. (NYSE: ANF), today announced a